Clinical Trial Update: Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma [NA]

View source ↗

Summary

Preclinical in vitro study evaluating the antitumor activity of GD2-targeted CAR-T cells against glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• GD2-CAR T cells

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Glioblastoma | NA | Status: NOT_YET_RECRUITING